The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large increase in short interest in February. As of February 28th, there was short interest totalling 13,500 shares, an increase of 17.4% from the February 13th total of 11,500 shares. Based on an average daily volume of 30,900 shares, the short-interest ratio is presently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ:CGABL opened at $17.78 on Friday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 1-year low of $17.48 and a 1-year high of $20.85. The stock’s fifty day simple moving average is $18.10 and its two-hundred day simple moving average is $18.91.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st were paid a dividend of $0.2891 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.50%. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date was Friday, January 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.